Agenus Inc - Company Profile
Powered by
All the data and insights you need on Agenus Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Agenus Inc Strategy Report
- Understand Agenus Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Agenus Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4275698A3 | Search Report | Anti-tigit antikörper und deren verwendung | A61K2039/57; A61K39/395; C07K16/2875; C07K2317/24; C07K2317/71; C07K2317/72; A61P35/04; G01N33/505; C07K2317/34; C07K16/30; C07K16/28; C07K2317/33; C07K2317/74; C07K2317/92; C07K2317/734; C07K2317/73; C07K2317/76; C07K16/2818; C07K16/2878; C07K2317/52; Y02A50/30; C07K2319/30 | May 15, 2024 |
WO2024097200A1 | Application | Methods of treating colorectal cancer using an anti-ctla4 antibody | C07K16/2818; A61K2039/507; A61P35/04; A61K2039/54; A61K2039/505; A61K2039/545 | May 10, 2024 |
WO2024098075A1 | Application | Invariant natural killer t cells for treating acute respiratory distress syndrome (ARDS) | May 10, 2024 | |
WO2024098026A2 | Application | B-cell maturation antigen (BCMA) chimeric antigen receptor invariant natural killer t cells and uses thereof | May 10, 2024 | |
US20240141047A1 | Application | Anti-tigit antibodies and methods of use thereof | A61K2039/57; A61K39/395; A61P35/04; C07K16/28; C07K16/2818; C07K16/2875; C07K16/2878; C07K16/30; C07K2317/33; C07K2317/34; C07K2317/52; C07K2317/71; C07K2317/72; C07K2317/73; C07K2317/734; C07K2317/74; C07K2317/76; C07K2317/92; G01N33/505 | May 02, 2024 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer